This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
See what results to expect from zero based budgeting and how to monitor progress with clear, actionable metrics.
19,375 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
Nvidia is poised to deliver another strong earnings quarter, but history shows a big print doesn’t always move the st...
Dell Technologies stunned markets with a Q1 FY27 results beat, led by AI-optimized servers and a rising backlog. The ...
Retail buzz around Celsius, Chewy, and Estée Lauder is pulsing through markets as earnings shape the near-term outloo...
A floated plan to require annual testosterone screening for service members 30 and older could reshape military healt...
As Herbalife wraps up 2025, investors seek clarity on growth, margins, and the path ahead. This article breaks down w...
PSEG's steady, regulated core supports its payout, but 2025 earnings hinge on rate cases, fuel costs, and clean energ...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...
Duolingo reported solid earnings, yet its stock moved lower. This article breaks down the investor psychology, the fo...
Cisco beat estimates on a robust AI infrastructure push, delivering record revenue and higher AI targets as the stock...
Investors are watching rayonier (ryn) 2026 earnings as timber demand and housing trends shape the outlook. This guide...